These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3931923)

  • 1. Comparative in vitro activity of eight antibiotics against Pseudomonas aeruginosa and infrequently isolated gram-negative bacilli.
    Chiaradia V; Pascoli L; Santini G
    Chemioterapia; 1985 Aug; 4(4):284-8. PubMed ID: 3931923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of imipenem towards gram-negative bacilli.
    Speciale A; Caccamo F; Pellegrino MB; Blandino G; Nicoletti G
    Chemioterapia; 1986 Oct; 5(5):291-6. PubMed ID: 3466723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
    Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
    Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
    Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
    Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance among gram-negative bacilli to newer aminoglycosides and beta-lactams.
    Jain S; Sarkar R
    Indian J Pathol Microbiol; 1991 Oct; 34(4):280-7. PubMed ID: 1818033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of six beta-lactams and six quinolones against urinary gram negative bacteria.
    Galante D; Esposito S; Barba D
    Boll Ist Sieroter Milan; 1986; 65(5):361-7. PubMed ID: 3828090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa.
    Pepeljnjak S; Kosalec I
    FEMS Microbiol Lett; 2004 Nov; 240(1):111-6. PubMed ID: 15500987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Pfaller MA; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bactericidal activity of beta-lactams and aminoglucosides: comparative evaluations].
    Dos Santos C; Monzillo V; Marone P; Concia E; Grossi P; Dughetti S
    Boll Ist Sieroter Milan; 1986; 65(5):374-9. PubMed ID: 3103652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro brodimoprim activity on bacterial strains.
    Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
    J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.